Semaglutide, the active ingredient in both Wegovy pills and the Wegovy injection, is a GLP-1 receptor agonist
At Australian Skin Clinics, were ready to take that journey with you
eLife 2014 , 116 (2014)
SURPASS-2 results (40 weeks, type 2 diabetes): Tirzepatide 5 mg: -7.6 kg weight loss, -2.01% HbA1c reduction Tirzepatide 10 mg: -9.3 kg weight loss, -2.24% HbA1c reduction Tirzepatide 15 mg: -11.2 kg weight loss, -2.30% HbA1c reduction Semaglutide 1 mg: -5.7 kg weight loss, -1.86% HbA1c reduction SURMOUNT-5 results (72 weeks, obesity): Tirzepatide demonstrated statistically superior weight loss compared to semaglutide 2.4 mg
Avoiding Toxins: Reducing alcohol, processed foods, and exposure to pollutants can help preserve your bodys glutathione levels
Discomfort, pain, bruising, inflammation, injury, and numbness at the site of injection